Anual Report

latest results

Interim results for the six months ended
30 June 2019

Vectura delivers strong financial performance during H1 2019



key figureS FROM 2018 PRELIMINARY RESULTS

£160.5m

Reported revenue

£39.0m

Adjusted EBITDA(1)

£108.2m

Cash and cash equivalents

(1) Adjusted EBITDA is a non-IFRS measures which is calculated as operating loss, adding back amortisation and impairment, depreciation, share-based payments and exceptional items.

Financial Calendar and events

Date Event Calendar downloads
11 to 13 December 2019 Drug Delivery to the Lungs (DDL) 2019, Edinburgh n/a
Date 11 to 13 December 2019
Event Drug Delivery to the Lungs (DDL) 2019, Edinburgh
Calendar downloads n/a

View all